| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. (LCTX) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 4 sells. LCTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $328.3K | - | |
| 10% | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | Hernandez Alexandra | Sr Director Finance/ Controller | Sale+OE | 6,000 | $2.23 | $13,380.00 | -100% | +27.9% | -33.6% | |
| Jan 2, 2020 | Lineage Cell Therapeutics, Inc. | Previous 10% Owner | Sell | 2,383,090 | $2.16 | $5,137,942.04 | -28.3% | - | - | |
| Sep 11, 2019 | Lineage Cell Therapeutics, Inc. | 10% Owner | Sell | 4,000,000 | $1.66 | $6,640,000.00 | -32.2% | - | - | |
| Aug 15, 2019 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 24,553 | $0.98 | $24,045.30 | - | - | - | |
| Aug 13, 2019 | Roberts Brandi | CFO &SVP, Finance | Buy | 5,000 | $1.01 | $5,050.00 | New | - | - | |
| Aug 13, 2019 | Culley Brian M56 | President And CEO | Buy | 10,000 | $1.01 | $10,100.00 | +13.4% | - | - | |
| Aug 13, 2019 | Leavitt Chase C. | General Counsel/ Secretary | Buy | 5,000 | $1.02 | $5,100.00 | New | - | - | |
| Jul 5, 2019 | Biotime Inc | 10% Owner | Sell | 2,250,000 | $2.00 | $4,500,000.00 | -15.3% | - | - | |
| Sep 11, 2018 | Andrews Deborah J | Director | Buy | 1,604 | $2.35 | $3,769.40 | +19.1% | - | - | |
| Oct 13, 2017 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 2,692,307 | $2.60 | $6,999,998.20 | +4.7% | - | - |